-
Pfizer and Bristol-Myers Squibb Could Face a Big Threat from Small Biotech Exelixis
The Motley Fool | On Oct. 10, Exelixis announced results from its phase 2 CABOSUN study of Cabometyx in patients with previously untreated advanced kidney cancer. This clinical trial was structured as a head-to-head comparison between Cabometyx and Pfizer's Sutent, and Cabometyx emerged as the clear winner.
Oct 17, 2016
-
Ewan Birney To Lead Global Alliance For Genomics and Health
Bio-IT World | The Global Alliance for Genomics in Health (GA4GH) has selected Ewan Birney, Director of the European Bioinformatics Institute (EMBL-EBI), to steward its member organizations in producing solutions for sharing genomic and clinical data. Birney took to his blog to address the new position.
Oct 14, 2016
-
Among the Multitude: A Look At The Complexity Of Diversity In Genetics
Bio-IT World | Genetics research is not as diverse as one would hope. Present discussions on this issue have led to the launching of multiple initiatives, including those from Illumina and 23andMe this week, whose goal is to develop the data pool in Africa.
Oct 13, 2016
-
IBMs Cleversafe Storage Platform Is Becoming A Cloud Service
Computerworld | The idea with IBM's new Cloud Object Storage service: If dispersing data among storage nodes can make it more secure and less prone to loss, spreading it across far-flung cloud data centers make it even more so.
Oct 13, 2016
-
IBM Workers to Use Watson Supercomputer to Find Cancer Treatments
Fortune | IBM announced that it will let its American workers use the Watson supercomputer technology in 2017 to find appropriate cancer treatments.
Oct 12, 2016
-
PierianDx Acquires Tute Genomics
Bio-IT World Brief PierianDx today announced the acquisition of Tute Genomics, a genomics software company based in Provo, UT, further increasing consolidation in the genomics space
Oct 12, 2016
-
Labfolder Deployed Across Max Planck Society
Bio-IT World Brief | Labfolder and the Max Planck Society today announced a licensing agreement to provide up to 11,000 Max Planck scientists from all disciplines ranging from physics, chemistry, life sciences and humanities with labfolder’s laboratory data management digital platform.
Oct 11, 2016
-
Q&A Confirming Next-Gen Sequencing Results with Sanger
The Scientist | Ambry Genetics CEO Aaron Elliott discusses his team's recent analysis of 20,000 clinical next-generation sequencing panels.
Oct 11, 2016
-
Panasas, HGST Offer iRODS Solution
Bio-IT World Brief | Yesterday Panasas and HGST announced a solution using iRODS to link the Panasas ActiveStor storage system with HGST’s object storage Active Archive System.
Oct 7, 2016
-
Bill Gates Succumbs to Moonshot Madness
Omics! Omics! Blog | Keith Robison comments on what he calls a misguided call for a moonshot in human disease from Bill Gates. Gates recently laid out four goals for disease prevention he believes can be attained in the next decade.
Oct 7, 2016
-
Biotech Billionaire Backs Company Geared At Ending Food Allergies
Forbes | Before Brands, a business that wants to prevent food allergies before they even start, launched this morning with $13.1 million in funding from backers including Gurnet Point, run by biotech billionaire Ernesto Bertarelli.
Oct 6, 2016
-
Dramatic Twists Could Upend Patent Battle Over CRISPR Genome-Editing Method
Science | AAAS | Unusual maneuver in CRISPR patent battle could divide spoils, but French company Cellectis also lays claim.
Oct 6, 2016
-
Rumors, Expectations Surround Apple Expansion Into Health Care
POLITICO | The tech giant is cementing partnerships with big health systems and hiring scores of health care professionals.
Oct 5, 2016
-
Gene Editing Takes the Stage at Discovery on Target 2016
Bio-IT World | In the Advances in Gene Editing, Gene Silencing, and Gene Therapy Tracks at the 2016 Discovery on Target conference, we heard from researchers on their exciting new advancements in CRISPR-CAS9 and beyond. The implications for cancer, anti-viral therapies, genetic diseases, and organ transplantation are vast.
Oct 4, 2016
-
Azure is becoming the first AI supercomputer says Microsoft
ZDNet | Microsoft's CEO on how its cloud computing service is evolving.
Oct 4, 2016
-
Biotech PR Needs to Deliver More Signal Less Noise
Forbes | It's hard to know how to get attention for your news these days. The Cambrian explosion of information on the Internet over the past decade has created a confusing world. PR firms have stepped right up to help biotech companies navigate it.
Oct 4, 2016
-
BARDA Awards Contract to DNAe to Develop Semiconductor DNA Sequencing Platform
Bio-IT World Brief | DNAe announced that BARDA has awarded the company a contract worth up to $51.9 million to develop its sequencing platform for rapid diagnosis in two key applications; antimicrobial resistant infections and influenza.
Oct 3, 2016
-
Oxford Nanopore’s Plans for Pre-Packaged Cas9 Test Kits
Bio-IT World | Oxford Nanopore Technologies is seeing more of a demand to focus on a subset of input materials, Clive Brown said this morning in his technical update. In addition to new pores, new chemistries, and updates on various devices, Brown dove into a Cas9 application that the company has been exploring and intimated that Oxford Nanopore will soon begin selling specific test kits for its mobile sequencers.
Sep 29, 2016
-
Oxford Nanopore Announces New Pores, Kits and Updates on Projects
Bio-IT World | The Chief Technology Officer at Oxford Nanopore gave a technical Oxford Nanopore update this morning, outlining updates on MinION, PromethION, SmidgeION, hardware and chemistries.
Sep 29, 2016
-
Cloud Pharmaceuticals, Rubicon Genomics, Bioz and more: News from September 2016
Bio-IT World News Briefs | News, products, and partnerships from around the bio-IT community including news from Cloud Pharmaceuticals, Rubicon Genomics, Bioz, and more.
Sep 29, 2016